View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
July 21, 2020

PHASE Scientific secures CE Mark approval for viral RNA extraction kit

US-based biotechnology company PHASE Scientific has received the CE Mark approval for its PHASIFY Viral RNA extraction kit.

US-based biotechnology company PHASE Scientific has received the CE Mark approval for its PHASIFY Viral RNA extraction kit.

The approval enables the company to expand commercialisation of the kits to the EU and other countries amid the ongoing fight against the Covid-19 pandemic.

PHASIFY is designed to purify and concentrate RNA in patient viral transport media samples. It facilitates greater SARS-CoV-2 RNA yields.

It improves input sample quality, enabling earlier detection and increased overall sensitivity and builds confidence in Covid-19 diagnostic test results.

According to the company, in-house and clinical validation data have shown that kit can offer a three-six cycle threshold reduction compared to solid-phase extraction.

Clinical studies have also found that the kit increases true positive detection compared to conventional solid-phase extraction.

This capability is fulfiled through PHASE Scientific’s proprietary technology PHASIFY that isolates and concentrates target molecules, making them easier to detect, the company said.

In addition, PHASIFY increases the sample input volume up to 600µL per extraction and enhances final viral RNA concentration with flexible elution volumes down to 10µL.

PHASE Scientific founder and CEO Ricky Chiu said: “PHASIFY VIRAL, as part of our many contributions for containing the global pandemic, marks a new step forward for both the company and our global collaborators in detecting and controlling the Covid-19 disease.

“Akin to other countries, we are confident our entry into the European market can benefit both healthcare providers and patients in the region to accelerate the return of healthier communities and the re-opening of global economies.”

PHASE Scientific noted that the viral RNA extraction kit is part of global efforts in detecting and containing the Covid-19 disease.

The company has developed a range of products, including antibody rapid tests, sample preparation kits and RT-qPCR kits to combat the virus.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network